Havrix 1,440 unit/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FMK6K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,260
Award facts
- Contract value 100% obligated
- $15,259.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 22, 2026, for the supply of HAVRIX 1,440 Unit/ML Syringe vaccine product, with a contract ceiling value of $15,259.92. This is a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, with no set-aside designation. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that has demonstrated extensive capability in supplying vaccines, medications, and specialized healthcare commodities to military and veteran healthcare systems through multiple competitive awards. The company's parent organization, Cencora, Inc., also maintains a significant IDC with the Defense Logistics Agency valued up to $999,999,999.00 through December 31, 2031, underscoring the company's strategic importance to federal medical supply chains and its ability to deliver essential pharmaceutical products across multiple therapeutic domains to government healthcare institutions globally.
Quick answers
Who was awarded contract SPE2DR26FMK6K?
SPE2DR26FMK6K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FMK6K worth?
The government has obligated $15,260 on SPE2DR26FMK6K.
Is contract SPE2DR26FMK6K an order under another contract?
Yes. SPE2DR26FMK6K is a delivery order under SPE2DR25D1200, an indefinite delivery contract.
Was contract SPE2DR26FMK6K competed?
The extent of competition for SPE2DR26FMK6K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award